Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 1, 2012
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2011.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus prior periods. It only confirms the issuance of results for the period ended December 31, 2011.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on March 1, 2012, regarding its financial results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2011.
- Verify year-over-year growth rates and margin trends not detailed in this summary.
- Check for any forward-looking guidance or updated risk factors included in the referenced press release.
- Confirm the status of the Company's liquidity and debt obligations as of December 31, 2011.